Next Article in Journal
Phenolic and Theobromine Contents of Commercial Dark, Milk and White Chocolates on the Malaysian Market
Previous Article in Journal
Coordination Modes of a Schiff Base Pentadentate Derivative of 4-Aminoantipyrine with Cobalt(II), Nickel(II) and Copper(II) Metal Ions: Synthesis, Spectroscopic and Antimicrobial Studies
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Pimarane-type Diterpenes: Antimicrobial Activity against Oral Pathogens

1
Núcleo de Pesquisa em Ciências Exatas e Tecnológicas, Universidade de Franca, Franca, SP, Brazil
2
Departamento de Ciências Farmacêuticas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil
*
Authors to whom correspondence should be addressed.
Molecules 2009, 14(1), 191-199; https://doi.org/10.3390/molecules14010191
Submission received: 24 November 2008 / Revised: 16 December 2008 / Accepted: 26 December 2008 / Published: 4 January 2009

Abstract

:
Seven pimarane type-diterpenes re-isolated from Viguiera arenaria Baker and two semi-synthetic pimarane derivatives were evaluated in vitro against the following main microorganisms responsible for dental caries: Streptococcus salivarius, S. sobrinus, S. mutans, S. mitis, S. sanguinis and Lactobacillus casei. The compounds ent-pimara-8(14),15-dien-19-oic acid (PA); ent-8(14),15-pimaradien-3b-ol; ent-15-pimarene-8b,19-diol; ent-8(14),15-pimaradien-3b-acetoxy and the sodium salt derivative of PA were the most active compounds, displaying MIC values ranging from 2 to 8 μg∙mL-1. Thus, this class of compounds seems promising as a class of new effective anticariogenic agents. Furthermore, our results also allow us to conclude that minor structural differences among these diterpenes significantly influence their antimicrobial activity, bringing new perspectives to the discovery of new natural compounds that could be employed in the development of oral care products.

Introduction

Dental caries is a common oral bacterial pathology caused by a biofilm consisting of microorganisms present on the tooth surface [1,2]. It is a disease that has been associated with Streptococcus spp., mainly Streptococcus mutans and S. sobrinus, and Lactobacillus spp. [3,4].
Mechanical removal of the dental plaque is the most efficient procedure in caries prevention; however, the majority of the population may not perform this removal efficiently [5]. Moreover, dental treatment is often very expensive and not readily accessible, especially in developing countries [6]. In this sense, extensive efforts have been made toward the search for anticariogenic compounds that can be incorporated into dental products [2, 7] aiming at complementing the mechanical removal of the biofilms from the oral cavity and reducing the incidence of caries in humans [1, 6].
Several antibiotics, such as ampicillin, chlorhexidine, sanguinarine, metronidazole, phenolic-antiseptics, and quaternary ammonium-antiseptics, among others, have been very effective in preventing dental caries [3, 8]. However, various adverse effects such as tooth and restoration staining, increasing of calculus formation, diarrhea, and disarrangements of the oral and intestinal flora have been associated with the use of these chemicals [3, 6]. These drawbacks justify the search for new effective anticariogenic compounds that could be employed in caries prevention.
The great diversity of the chemical structures of secondary plant metabolites continues to provide new and important leads against several pharmacological targets [9,10]. Recent studies have demonstrated the great importance of natural products, both plant extracts and isolated compounds, as natural antibacterial agents in oral care products [2,3, 6, 8]. Chung et al. [3] have described the specific activity and fast effectiveness of macelignan isolated from Myristica fragrans against oral bacteria. Katsura et al. [11] have pointed out the great potential of bakuchiol for use in mouthwash for prevention and treatment of dental caries, while More et al. [6] have provided insight into the antibacterial properties of the extracts traditionally used in South Africa to prevent and treat of oral problems.
Recently, our research group has demonstrated that kaurenoic acid, a diterpene isolated from Aspilia foliacea, could be used as a prototype for the discovery of new effective anti-infection agents against pathogens responsible for caries and periodontal diseases [2]. The study showed that kaurane-type diterpenes can be potentially useful in the development of natural anti-caries and anti-periodontal agents [2]. In view of these results, we have decided to investigate the antimicrobial activity of plant extracts containing other classes of diterpenes. In the present work we describe the effective antimicrobial activity displayed by the dichloromethane root extract from Viguiera arenaria (VaDRE) (Asteraceae), as well as the activity of the mainly isolated and two semi-synthetic pimarane-type diterpenes against some oral microorganisms, including Streptococcus mutans, which is considered one of the primary causative agents of dental caries [3].

Results and Discussion

The chemical structures of the diterpenes studied in this work are presented in Figure 1. The spectral data of all compounds are in agreement with those previously reported in the literature: 1,2, 3, 6 and 7 [12,13]; 4 [14]; and 5 [15]. The 1H- and 13C-NMR spectral data analysis of the semi-synthetic derivatives, as well as, comparison with literature [12,13,14] allowed us to establish their structures.
Figure 1. Chemical structures of the pimarane diterpenes from Viguiera arenaria.
Figure 1. Chemical structures of the pimarane diterpenes from Viguiera arenaria.
Molecules 14 00191 g001
In this study we demonstrate the significant inhibitory effect that some pimarane-type diterpenes display on the growth of the main microorganisms responsible for dental caries. Among the evaluated metabolites, compounds 2, 4, 6, 8 and 9 displayed the highest antibacterial activity (Table 1), showing minimum inhibitory concentration (MIC) values lower than 10µg∙mL-1 for all dental caries pathogens. Chlorhexidine dihydrochloride was used as positive control, and all MIC values for each microorganism are also described in Table 1. The negative control (4 % DMSO solution) did not affect the growth of the evaluated microorganisms.
According to Ríos and Recio [16], some considerations must be born in mind in the study of antimicrobial assays of plant extracts, essential oils, and compounds isolated from natural sources. These authors have emphasized that MIC values higher than 1 mg∙mL-1 for extracts or 0.1 mg∙mL-1 for pure metabolites should be avoided, whereas activities in concentrations below 100 μg∙mL-1 and 10 μg∙mL-1 for extracts and isolated compounds, respectively, are very promising [16]. Based on these criteria the natural diterpenes 2, 4 and 6, as well as the semi-synthetic compounds 8 and 9, can be classified as potential prototypes for the discovery of new effective anticariogenic agents. Some compounds with potential activity against oral microorganisms have been found in nature. Tsui et al. [8] have shown that naringin, a flavonoid that is commonly found in grapefruits, has significant antimicrobial properties against periodontal pathogens in vitro. Sanguinarine, an alkaloid isolated from the rhizome of Sanguinaria canadensis, has been shown to be a broad spectrum antibacterial agent against various oral bacteria. It has been used as an anticariogenic agent in a wide range of oral care products such as toothpastes and mouthwashes [17], but is industrial application has been dramatically reduced because the use of this compound has been associated with oral leukoplakia [18].
Table 1. In vitro antibacterial activity (MIC) of the pimarane-type diterpenes against oral pathogens.
Table 1. In vitro antibacterial activity (MIC) of the pimarane-type diterpenes against oral pathogens.
CompoundMinimum inhibitory concentration – μg∙mL-1 (μM)
Microorganism
L. caseiS. mitisS. mutansS. sanguinisS. sobrinusS. salivarius
VaDRE12.010.012.010.010.010.0
1******
23.0 (9.9)4.0 (13.2)4.5 (14.9)2.5 (8.3)4.0 (13.2)5.0 (16.5)
3******
42.5 (8.7)4.0 (13.9)2.5 (8.7)4.5 (15.6)6.0 (20.8)4.0 (13.9)
5******
66.0 (19.6)4.0 (13.1)6.0 (19.6)6.0 (19.6)4.0 (13.1)3.0 (7.8)
7*16.0 (50.2)20.0 (62.8)*16.0 (50.2)*
86.0 (18.2)8.0 (24.2)6.0 (18.2)6.0 (18.2)6.0 (18.2)8.0 (24.2)
92.0 (6.2)3.0 (9.3)2.5 (7.7)2.5 (7.7)4.0 (12.3)3.5 (10.8)
PC0.0922 (0.16)0.3688 (0.64)0.0922 (0.16)0.7375 (1.27)0.0922 (0.16)0.0922 (0.16)
* Inactive in the evaluated concentrations (MIC values higher than 80 μg∙mL-1); Positive Control (PC) – Chlorhexidine dihydrochloride; Negative control (4 % DMSO solution) did not affect the growth of the microorganisms.
As previously mentioned, our research group has demonstrated that kaurane-type diterpenes can be potentially employed in the further development of natural anti-caries agents. The great importance of understanding the structure-activity relationships of these metabolites has also been pointed out, since minor structural alterations may improve their activities against oral bacteria. Similarly, on the basis of the results presented in Table 1, it is possible to verify that the pimarane-type diterpenes are another important source of secondary plant metabolites with potential for the development of new effective anti-infection agents against microorganisms responsible for caries diseases.
Recently, Urzúa et al. [19] have established that a lipophilic decalin ring system, with a strategically positioned hydrogen-bond-donor group (HBD; hydrophilic group), is very important for the antimicrobial activity displayed by diterpenes. Moreover, in this same study the authors pointed out that a second HBD introduced in the decalin ring system led to a reduction in or suppression of the activity. They argued that there were basically two reasons that may explain the reduced antibacterial activity displayed by diterpenoids containing two hydrogen-bond-donor groups: 1) the presence of two HBDs decrease the lipophilicity of the hydrophobic moiety, hindering its interaction with the bacterial membrane; 2) the intramolecular HBD group interactions compete with intermolecular hydrogen-bonds between each HBD and the cell membrane.
A careful observation of the results in Table 1 reveals that compounds 2, 4, 6, 8 and 9, which contain a HBD at C-3 or C-19, display MIC values much lower than that of compound 1, which has no HBD in its chemical structure. In fact, the presence of two HBDs in the decalin ring system of compounds 3, 5 and 7 really decreases the antimicrobial activity displayed by the pimarane-type diterpenes considerably. In this sense, our results are in complete agreement with those previously reported by Urzúa et al. [19]. However, comparison of the MIC values displayed by compound 2 against Streptococcus salivarius (16.5 μM), S. sobrinus (13.2 μM), S. mutans (14.9 μM), S. mitis (13.2 μM), S. sanguinis (8.3 μM) and Lactobacillus casei (9.9 μM) with the values previously described for ent-kaur-16(17)-en-19-oic-acid (Figure 2; MIC values higher than 33.06 μM for all oral pathogens) [2] leads to the conclusion that the antimicrobial activity observed for these chemicals is also ruled by other structural factors. These drawbacks highlight the great importance of studying other classes of diterpenes as well as their semi-synthetic derivatives. These studies may help to determine, in a structure-activity context, which other factors contribute to the antimicrobial activity displayed by these metabolites.
Figure 2. Chemical structure of ent-kaur-16(17)-en-19-oic-acid.
Figure 2. Chemical structure of ent-kaur-16(17)-en-19-oic-acid.
Molecules 14 00191 g002
Comparing the MIC values of 6 with those of 3, 5 and 7, we clearly observe that the proximity between the hydrophilic groups in the latter three significantly reduces their antibacterial activity. This supports the hypothesis of Urzúa et al., who describe that the intramolecular interactions between the two HBDs decrease the antimicrobial activity of diterpenes. On the other hand, when the MIC values of 6 and 8 are compared, it is clear that the decrease in lipophilicity and the sucessive decrease in activity, due to the presence of two HBDs, does not work in our case.

Conclusions

The reports on the antimicrobial activity of natural products against the pathogens responsible for caries diseases are scarce. However, by comparing the MIC values against oral pathogens displayed by some pimarane type-diterpenes described here with MIC values previously published in the literature [2,7,20,21], one can conclude that the pimarane-type diterpenes may be potentially employed in the further development of natural anti-caries agents. Moreover, this work has highlighted the great importance of evaluating other classes of diterpenes as well as their semi-synthetic derivatives, since these studies may help determine the potential of diterpenes as antimicrobial agents. The comparison of the results obtained here with the hypothesis sustained by Úrzua et al. [19] establishes the need for a larger number of structures with known activities to totally clarify the structure-activity relationship.

Experimental

General

NMR spectra were run on a Bruker DPX 400 spectrometer (400 MHz for 1H and 100 MHz for 13C). Samples were dissolved in CDCl3 or CD3OD, and the spectra were calibrated with the solvent signals at 7.26 and 3.30/4.84 (1H) or 77.0 and 49.0 (13C), respectively; the chemical shifts are given in ppm.

Plant material

Viguiera arenaria Baker (Asteraceae) was collected by Fernando Batista da Costa from the vicinity of the Washington Luís highway (km 223, 22°10 S, 47°59 W, SP, Brazil, in March 1999). The plant material was identified by J. N. Nakajima (Universidade Federal de Uberlândia, MG, Brazil) and E. E. Schilling (University of Tennessee, TN, USA). A voucher specimen (FBC 60) was deposited in the herbarium of the Departamento de Biologia, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo, SP, Brazil, with the code SPFR 4006.

Extraction and isolation

An aliquot (8.0 g) of the dichloromethane root crude extract from V. arenaria (VaDRE), which was prepared in our laboratory in 1999, was suspended in a MeOH/H2O solution (9:1 v/v) and partitioned with n-hexane and dichloromethane (DCM). The n-hexane (2.0 g) and DCM extracts (1.0 g) were re-fractioned using several chromatographic techniques, such as vacuum liquid chromatography, flash chromatography, and preparative thin layer chromatography, as well as recrystallization with methanol, as previously described [22,23]. These procedures furnished 100 mg of ent-8(14),15-pimaradiene (1); 200 mg of ent-pimara-8(14),15-dien-19-oic acid (PA; 2); 7 mg of 7-keto-ent-pimara-8(14),15-dien-19-oic acid (3); 100 mg of ent-8(14),15-pimaradien-3b-ol (4); 20 mg of ent-8(14),15-pimaradiene-3b,19-diol (5); 5 mg of ent-15-pimarene-8b,19-diol (6); and 20 mg 7b-hydroxy-ent-pimara-8(14),15-dien-19-oic acid (7).

Semi-synthetic derivatives

About 50 mg of 4 were treated with excess acetic anhydride in pyridine according to Da Costa et al. [24], to give 37 mg of the C-3 acetoxyl derivate ent-8(14),15-pimaradien-3b-acetoxy (8). This compound was purified through flash chromatography with n-hexane/ethyl acetate (9:1 v/v) as the mobile phase and identified by means of spectrometric analysis and comparison with literature data [14]. 1H-NMR: δ 4.52 (1H, dd, J=4.2, 11.7 Hz, H-3); 5.14 (1H, s (br), H-14); 5.71 (1H, dd, J=10.3, 17.2 Hz, H-15); 4.90 (1H, dd, J=2.0, 17.2 Hz, H-16a); 4.95 (1H, dd, J=2.0, 10.3 Hz, H-16b); 0.99 (3H, s, H-17); 0.88 (3H, s, H-18); 0.88 (3H, s, H-19); 0.75 (3H, s, H-20); 2.05 (3H, s, H-22 (OCOCH3)); 13C-NMR: δ 38.3 (C-1); 28.7 (C-2); 81.4 (C-3); 37.2 (C-4); 54.6 (C-5); 21.7 (C-6); 35.9 (C-7); 138.3 (C-8); 51.5 (C-9); 38.4 (C-10); 19.5 (C-11); 36.0 (C-12); 39.0 (C-13); 128.7 (C-14); 147.7 (C-15); 113.3 (C-16); 29.8 (C-17); 22.4 (C-18); 17.3 (C-19); 15.2 (C-20); 171.5 (C-21 (COCH3)); 24.5 (C-22 (COCH3)).
PA (2, 50 mg) was dissolved in n-hexane (5 mL) and shaken with a NaOH solution (0.5 mol∙L-1, 5 mL) according to Daló et al. [25]. The aqueous phase, which contained the sodium salt of PA (9) as an emulsion, was filtered in a Büchner funnel, yielding 40 mg of the salt derivative after being washed with cold water. The chemical structure of this compound was established using 1H- and 13C-NMR spectral data analysis and comparison with literature data [12,13]. 1H-NMR: δ 5.11 (1H, s (br), H-14); 5.70 (1H, dd, J=10.2, 16.3 Hz, H-15); 4.91 (1H, dd, J=2.1, 16.3 Hz, H-16a); 4.95 (1H, dd, J=2.1, 10.2 Hz, H-16b); 0.96 (3H, s, H-17); 1.15 (3H, s, H-18); 0.71 (3H, s, H-20); 13C-NMR: δ 42.1 (C-1); 21.3 (C-2); 40.6 (C-3); 46.9 (C-4); 58.7 (C-5); 26.9 (C-6); 38.0 (C-7); 141.2 (C-8); 53.2 (C-9); 42.1 (C-10); 22.3 (C-11); 38.9 (C-12); 41.4 (C-13); 129.4 (C-14); 149.5 (C-15); 114.5 (C-16); 31.4 (C-17); 31.0 (C-18); 185.2 (C-19); 15.7 (C-20).

Purity of the evaluated diterpenes

The purity of each diterpene (1-9 - Figure 1) was estimated by thin-layer chromatography using different solvent systems. They were also submitted to 1H and 13C NMR spectral data analysis, which indicated a purity between 95-98% for each compound.

Antimicrobial assays

The MIC values (the lowest concentration of the compound capable of inhibiting microorganism growth) of the DCM root extract from V. arenaria and the pure diterpenes were determined in triplicate using the microdilution broth method [26] in 96-well microplates. Standard strains from the American Type Culture Collection of the following microorganisms were used: Streptococcus salivarius (ATCC 25975), Streptococcus sobrinus (ATCC 33478), Streptococcus mutans (ATCC 25275), Streptococcus mitis (ATCC 49456), Streptococcus sanguinis (ATCC 10556), and Lactobacillus casei (ATCC 11578). The samples were dissolved in DMSO (dimethyl sulfoxide) at 1 mg∙mL-1, followed by dilution in tryptic soy broth; concentrations ranging from 80 to 1 mg∙mL-1 were achieved. The final DMSO content was 4% (v/v), and this solution was used as negative control. The inoculum was adjusted for each organism, to yield a cell concentration of 5 x 105 colony forming units (CFU)∙mL-1. One inoculated well was included, to allow control of the adequacy of the broth for organism growth. One non-inoculated well, free of antimicrobial agent, was also included, to ensure medium sterility. Chlorhexidine dihydrochloride was used as positive control. The microplates (96 - wells) were sealed with plastic film and incubated at 37 °C for 24 h. After that, resazurin (30 mL) in aqueous solution (0.02%) was added to the microplates, to indicate microorganism viability. This procedure was based on the methodology described by Palomino et al. [27].

Acknowledgements

The authors thank FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paulo) for funds and grants (processes no. 2007/54762-8 and 2007/59017-9).

References

  1. Allaker, R.P.; Douglas, C.W.I. Novel anti-microbial therapies for dental plaque-related diseases. Int. J. Antimicrob. Agents 2008. [Google Scholar]
  2. Ambrosio, S.R.; Furtado, N.A.J.C; De Oliveira, D.C.R.; Da Costa, F. B.; Martins, C.H.G.; De Carvalho, T.C.; Porto, T.S.; Veneziani, R.C.S. Antimicrobial activity of kaurane diterpenes against oral pathogens. Z. Naturforsch. 2008, 63c, 326–330. [Google Scholar]
  3. Chung, J.Y.; Choo, J.H.; Lee, M.H.; Hwang, J.K. Anticariogenic activity of macelignan isolated from Myristica fragrans (nutmeg) against Streptococcus mutans. Phytomedicine 2006, 13, 261–266. [Google Scholar] [CrossRef]
  4. Hirasawa, M.; Takada, K. Susceptibility of Streptococcus mutans and Streptococcus sobrinus to cell wall inhibitors and development of a novel selective medium for S. sobrinus. Caries Res. 2002, 36, 155–160. [Google Scholar] [CrossRef]
  5. Haffajee, A.D.; Yaskell, T.; Socransky, S.S. Antimicrobial effectiveness of an herbal mouthrinse compared with an essential oil and a chlorhexidine mouthrinse. J. Am. Dent. Assoc. 2008, 139, 606–611. [Google Scholar]
  6. More, G.; Tshikalange, T.E.; Lall, N.; Botha, F.; Meyer, J.J.M. Antimicrobial activity of medicinal plants against oral microorganisms. J. Ethnopharmacol. 2008, in press. [Google Scholar]
  7. Cai, L.; Wu, C.D. Compounds from Syzygium aromaticum possessing growth inhibitory activity against oral pathogens. J. Nat. Prod. 1996, 59, 987–990. [Google Scholar] [CrossRef]
  8. Tsui, V.W.K.; Wong, R.W.K.; Rabie, A.B.M. The inhibitory effects of narigin on the growth of periodontal pathogens in vitro. Phytother. Res. 2008, 22, 401–406. [Google Scholar] [CrossRef]
  9. Fabricant, D.S.; Farnsworth, N.R. The value of plants used in traditional medicine for drug discovery. Environ. Health. Persp. 2001, 109, 69–75. [Google Scholar]
  10. Balunas, M.J.; Kinghorn, A.D. Drug discovery from medicinal plants. Life Sci. 2005, 78, 431–441. [Google Scholar] [CrossRef]
  11. Katsura, H.; Tsukiyama, R.I.; Suzuki, A.; Kobayashi, M. In vitro antimicrobial activities of bakuchiol against oral microorganisms. Antimicrob. Agents Chemother. 2001, 45, 3009–3013. [Google Scholar] [CrossRef]
  12. Mihashi, S. Further study on the diterpenes of Aralia spp. Tetrahedron Lett. 1969, 21, 1683–1686. [Google Scholar] [CrossRef]
  13. Matsuo, A.; Uto, S.; Nakayama, M.; Hayashi, S.; Yamasaki, K.; Kasai, R.; Tanaka, H. Thermarol, a new ent-pimarane-class diterpene diol from Jungermannia thermarum (Liverwort). Tetrahedron Lett. 1976, 28, 2451–2454. [Google Scholar]
  14. Ansell, S.M.; Pegel, K.H.; Taylor, D.A.H. Diterpenes from the timber of 20 Erythroxylum species. Phytochemistry 1993, 32, 953–959. [Google Scholar] [CrossRef]
  15. Garcia, E.E.; Guerreiro, E.; Joseph-Nathan, P. Ent-pimaradiene diterpenes from Gochnatia glutinosa. Phytochemistry 1985, 24, 3059–3060. [Google Scholar] [CrossRef]
  16. Ríos, J.L.; Recio, M.C. Medicinal plants and antimicrobial activity. J. Ethnopharmacol. 2005, 100, 80–84. [Google Scholar] [CrossRef]
  17. Eley, B.M. Antibacterial agents in the control of supragingival plaque – a review. Br. Dent. J. 1999, 186, 286–296. [Google Scholar]
  18. Mascarenhas, A.K.; Allen, C.M.; Loudon, J. The association between Viadent use and oral leukoplakia. Epidemiology 2001, 12, 741–743. [Google Scholar] [CrossRef]
  19. Urzúa, A.; Rezende, M.C.; Mascayano, C.; Vásquez, L. A structure-activity study of antibacterial diterpenoids. Molecules 2008, 13, 882–891. [Google Scholar] [CrossRef]
  20. Tsuchiya, H.; Sato, M.; Iinuma, M.; Yokoyama, J.; Tanaka, T.; Takase, I.; Namikawa, I. Inhibition of the growth of cariogenic bacteria in vitro by plant flavanones. Experientia 1994, 50, 846–849. [Google Scholar] [CrossRef]
  21. Cunha, S.L.C.; Silva, M.L.A.; Furtado, N.A.J.C.; Vinhólis, A.H.C.; Martins, C.H.G; Silva-Filho, A.A.; Cunha, W.R. Antibacterial activity of triterpene acids and semi-synthetic derivatives against oral pathogens. Z. Naturforsch. 2007, 62c, 668–672. [Google Scholar]
  22. Ambrosio, S.R.; Schorr, K.; Da Costa, F. B. Terpenoids of Viguiera arenaria (Asteraceae). Biochem. Syst. Ecol. 2004, 32, 221–224. [Google Scholar] [CrossRef]
  23. Ambrosio, S.R.; Arakawa, N.S.; Esperandim, V.R.; de Albuquerque, S.; Da Costa, F.B. Trypanocidal activity of pimarane diterpenes from Viguiera arenaria (Asteraceae). Phytother. Res. 2008, 22, 1413–1415. [Google Scholar] [CrossRef]
  24. Da Costa, F.B.; Vichnewiski, W.; Herz, W. Diterpenes and synthetic derivatives from Viguiera aspillioides with trypanomicidal activity. Planta Med. 1996, 62, 557–559. [Google Scholar] [CrossRef]
  25. Daló, N.L.; Sosa-Sequera, M.C.; Usubillaga, A. On the anticonvulsant activity of kaurenic acid. Invest. Clin. 2007, 48, 349–358. [Google Scholar]
  26. National Committee for Clinical Laboratory Standards. NCCLS document M7-A6 - Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; NCCLS: Wayne, PA, 2003. [Google Scholar]
  27. Palomino, J.C.; Martin, A.; Camacho, M.; Guerra, H.; Swings, J.; Portaels, S. Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistence in Mycobacterium tuberculosis. Antimicrob. Agents Chem. 2002, 46, 2720–2722. [Google Scholar] [CrossRef]
  • Sample Availability: Samples are not available.

Share and Cite

MDPI and ACS Style

Porto, T.S.; Rangel, R.; Furtado, N.A.J.C.; De Carvalho, T.C.; Martins, C.H.G.; Veneziani, R.C.S.; Da Costa, F.B.; Vinholis, A.H.C.; Cunha, W.R.; Heleno, V.C.G.; et al. Pimarane-type Diterpenes: Antimicrobial Activity against Oral Pathogens. Molecules 2009, 14, 191-199. https://doi.org/10.3390/molecules14010191

AMA Style

Porto TS, Rangel R, Furtado NAJC, De Carvalho TC, Martins CHG, Veneziani RCS, Da Costa FB, Vinholis AHC, Cunha WR, Heleno VCG, et al. Pimarane-type Diterpenes: Antimicrobial Activity against Oral Pathogens. Molecules. 2009; 14(1):191-199. https://doi.org/10.3390/molecules14010191

Chicago/Turabian Style

Porto, Thiago S., Rander Rangel, Niege A. J. C. Furtado, Tatiane C. De Carvalho, Carlos H. G. Martins, Rodrigo C. S. Veneziani, Fernando B. Da Costa, Adriana H. C. Vinholis, Wilson R. Cunha, Vladimir C. G. Heleno, and et al. 2009. "Pimarane-type Diterpenes: Antimicrobial Activity against Oral Pathogens" Molecules 14, no. 1: 191-199. https://doi.org/10.3390/molecules14010191

Article Metrics

Back to TopTop